Affective symptoms and swallow-specific quality of life in total laryngectomy patients.


Journal

Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541

Informations de publication

Date de publication:
11 2020
Historique:
received: 11 10 2019
revised: 26 05 2020
accepted: 16 06 2020
pubmed: 6 7 2020
medline: 22 6 2021
entrez: 5 7 2020
Statut: ppublish

Résumé

The aim of this study is to determine the prevalence of clinically relevant affective symptoms and level of swallow-specific quality of life (QoL) in dysphagic patients with total laryngectomy (TL) and to explore the relationship between affective symptoms and swallow-specific QoL. Thirty-five TL patients completed the Hospital Anxiety and Depression Scale (HADS) and the MD Anderson Dysphagia Inventory (MDADI). Student's t test and linear regression were used. Eight (23%) patients showed clinically relevant symptoms of anxiety, 8 (23%) of depression, and 11 (31%) showed either one. These groups had significantly lower mean MDADI scores. One-point increase in HADS-anxiety or HADS-depression subscale score corresponds with a decrease of 2.7 or 3.0 points, on average, respectively, of the MDADI total score. Clinically relevant affective symptoms were present in approximately one-third of the TL patients. These preliminary results show that increased affective symptom scores correlate with a decreased swallow-specific QoL.

Sections du résumé

BACKGROUND
The aim of this study is to determine the prevalence of clinically relevant affective symptoms and level of swallow-specific quality of life (QoL) in dysphagic patients with total laryngectomy (TL) and to explore the relationship between affective symptoms and swallow-specific QoL.
METHODS
Thirty-five TL patients completed the Hospital Anxiety and Depression Scale (HADS) and the MD Anderson Dysphagia Inventory (MDADI). Student's t test and linear regression were used.
RESULTS
Eight (23%) patients showed clinically relevant symptoms of anxiety, 8 (23%) of depression, and 11 (31%) showed either one. These groups had significantly lower mean MDADI scores. One-point increase in HADS-anxiety or HADS-depression subscale score corresponds with a decrease of 2.7 or 3.0 points, on average, respectively, of the MDADI total score.
CONCLUSIONS
Clinically relevant affective symptoms were present in approximately one-third of the TL patients. These preliminary results show that increased affective symptom scores correlate with a decreased swallow-specific QoL.

Identifiants

pubmed: 32621568
doi: 10.1002/hed.26365
pmc: PMC7586820
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

3179-3187

Informations de copyright

© 2020 The Authors. Head & Neck published by Wiley Periodicals LLC.

Références

Br J Cancer. 2001 Jan;84(2):149-56
pubmed: 11161369
Arch Phys Med Rehabil. 2005 Aug;86(8):1516-20
pubmed: 16084801
J Psychosom Res. 2017 Jun;97:102-110
pubmed: 28606489
Psychol Med. 1997 Mar;27(2):363-70
pubmed: 9089829
Laryngoscope. 2016 May;126(5):1108-13
pubmed: 26542529
J Affect Disord. 2010 Nov;126(3):335-48
pubmed: 20207007
Acta Otorrinolaringol Esp. 2015 Jul-Aug;66(4):210-7
pubmed: 25465282
J Psychosom Res. 2002 Feb;52(2):69-77
pubmed: 11832252
Dysphagia. 2011 Dec;26(4):407-14
pubmed: 21279522
Laryngoscope. 1996 Apr;106(4):490-4
pubmed: 8614227
J Laryngol Otol. 2009 Nov;123(11):1229-32
pubmed: 19607738
Head Neck. 2006 Apr;28(4):313-20
pubmed: 16200627
Head Neck. 2012 Jan;34(1):59-65
pubmed: 21416548
Radiother Oncol. 2009 Jul;92(1):4-14
pubmed: 19446902
Curr Opin Otolaryngol Head Neck Surg. 2013 Jun;21(3):224-9
pubmed: 23644734
Otolaryngol Head Neck Surg. 2011 Jan;144(1):21-8
pubmed: 21493382
Head Neck. 2018 Dec;40(12):2733-2748
pubmed: 30478930
Eur Arch Otorhinolaryngol. 2010 Apr;267(4):593-600
pubmed: 19760214
Oncol Nurs Forum. 2010 May;37(3):293-301
pubmed: 20439213
J Am Med Dir Assoc. 2017 Jan;18(1):53-58
pubmed: 27624705
Head Neck. 2020 Nov;42(11):3179-3187
pubmed: 32621568
Anticancer Res. 2019 May;39(5):2527-2533
pubmed: 31092449
J Laryngol Otol. 2012 Jan;126(1):52-7
pubmed: 21867586
J Cardiopulm Rehabil Prev. 2019 Nov;39(6):E6-E11
pubmed: 30489438
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Dysphagia. 2009 Jun;24(2):172-9
pubmed: 18784911
Arch Otolaryngol Head Neck Surg. 2001 Jul;127(7):870-6
pubmed: 11448365
Clinics (Sao Paulo). 2005 Apr;60(2):135-42
pubmed: 15880250
Dysphagia. 2009 Sep;24(3):314-21
pubmed: 19290578
J Dent Res Dent Clin Dent Prospects. 2017 Fall;11(4):247-252
pubmed: 29354252
Psychiatry Res. 2017 Oct;256:6-12
pubmed: 28618249
HNO. 2016 Mar;64(3):163-8
pubmed: 26923487
Semin Radiat Oncol. 2009 Jan;19(1):35-42
pubmed: 19028344
Int J Lang Commun Disord. 2015 Jul;50(4):467-75
pubmed: 25703153
Psychother Psychosom Med Psychol. 2007 Aug;57(8):328-33
pubmed: 17334971

Auteurs

Glen J F Kemps (GJF)

Department of Otorhinolaryngology, Head and Neck Surgery, Maastricht University Medical Center, Maastricht, The Netherlands.
School for Oncology and Developmental Biology (GROW), Maastricht University, Maastricht, The Netherlands.

Iris Krebbers (I)

Department of Otorhinolaryngology, Head and Neck Surgery, Maastricht University Medical Center, Maastricht, The Netherlands.
School for Oncology and Developmental Biology (GROW), Maastricht University, Maastricht, The Netherlands.

Walmari Pilz (W)

Department of Otorhinolaryngology, Head and Neck Surgery, Maastricht University Medical Center, Maastricht, The Netherlands.
School of Mental Health and Neurosciences (MHeNS), Maastricht University, Maastricht, The Netherlands.

Sophie Vanbelle (S)

Department of Methodology and Statistics, Maastricht University, Maastricht, The Netherlands.
Care and Public Health Research Institute - CAPHRI, Maastricht University Medical Center, Maastricht, The Netherlands.

Laura W J Baijens (LWJ)

Department of Otorhinolaryngology, Head and Neck Surgery, Maastricht University Medical Center, Maastricht, The Netherlands.
School for Oncology and Developmental Biology (GROW), Maastricht University, Maastricht, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH